MN SF4058 | 2023-2024 | 93rd Legislature

Status

Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on February 22 2024 - 25% progression
Action: 2024-02-22 - Referred to Health and Human Services
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Commissioner of human services authorization to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Commissioner of human services authorization to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases

Sponsors


History

DateChamberAction
2024-02-22SenateReferred to Health and Human Services
2024-02-22SenateIntroduction and first reading

Same As/Similar To

HF3664 (Similar To) 2024-03-18 - Author added Hemmingsen-Jaeger

Minnesota State Sources


Bill Comments

feedback